Today: 18 May 2026
Circle (CRCL) stock jumps again after hours as Mizuho lifts target to $100 on oil, rate worries
3 March 2026
2 mins read

Circle (CRCL) stock jumps again after hours as Mizuho lifts target to $100 on oil, rate worries

New York, March 3, 2026, 5:16 PM EST — Trading after the bell.

  • Shares rose as much as $104.30 before pulling back; last up 3.6% at $99.63
  • Mizuho bumped its Circle price target up to $100, pointing to dwindling chances of the Fed cutting rates anytime soon.
  • CFO Jeremy Fox-Geen filed a Form 144, signaling a modest planned sale under Rule 144.

Circle Internet Group (CRCL) climbed 3.6% to $99.63 in after-hours trading on Tuesday, building on a two-day rally that followed Mizuho’s price target hike for the stablecoin issuer. Earlier in the session, shares reached as high as $104.30. Volume was hefty—roughly 33 million shares changed hands.

Circle is the company behind USD Coin, or USDC, a stablecoin pegged one-to-one with the U.S. dollar. Cash backing the tokens goes mostly into short-term Treasuries and deposits. That means Circle’s profits shift with U.S. interest rates.

Traders are once again watching that link, trying to gauge if the Federal Reserve is positioned to cut rates soon. Oil prices, meanwhile, are climbing as Middle East tensions persist.

Dan Dolev at Mizuho Securities bumped his price target up to $100 from $90 but stuck with a neutral call, warning that oil-driven inflation could delay rate cuts. “Rising oil prices could drive up inflation, lowering the odds of rate cuts,” Dolev said. TheStreet

Circle shares surged 15.2% Monday, pushing its post-earnings rally further and cementing the stock’s reputation as a go-to gauge for rates and crypto moves among traders. Gains cooled off late Tuesday, though Circle still closed the session above water.

Chief Financial Officer Jeremy Fox-Geen signaled plans to offload 4,238 Class A shares, according to a Form 144 filed Tuesday, the shares linked to a March 1 restricted stock vesting. The same document pointed to earlier transactions: Fox-Geen sold 47,908 shares on Feb. 26, then another 7,200 on March 2. The filing cited a Rule 10b5-1 trading plan, put into place in August 2025. Form 144 serves as advance notice for company insiders aiming to sell stock under SEC Rule 144, which governs the resale of certain securities.

Circle’s most recent moves follow last week’s earnings surprise, as the company topped Wall Street estimates thanks to a 72% surge in USDC circulation, now at $75.3 billion, and $733 million in reserve income. “The key takeaway is that USDC continues scaling rapidly,” Seaport Research Partners analyst Jeff Cantwell said at the time. CEO Jeremy Allaire told Reuters he’d “welcome” additional rate cuts, even though higher rates pad reserve income. Reuters

Circle puts its stablecoin reserves into short-term government debt and cash, pocketing the yield—so it stands to gain when policy remains tight. That setup also lets the stock sometimes move in line with short-term rates, especially on quieter crypto news days.

But when markets swing risk-off, crypto activity tends to get squeezed, and demand for stablecoins often drops. Circle is also up against rival dollar-backed tokens and payments companies moving further into blockchain settlement.

Still, the trade can unwind fast. If oil prices tumble or softer U.S. numbers push up hopes for earlier rate cuts, Circle’s reserve income outlook takes a hit. More insider selling could also dump extra supply onto shares that have already surged in little time.

Focus shifts now to fresh U.S. numbers and what’s next out of the Fed. Traders are keyed in on Friday’s jobs data (March 6), then the CPI for February coming March 11. All eyes, of course, on the Fed’s policy meeting set for March 17–18.

Latest articles

Quince Therapeutics Stock Faces Nasdaq Pressure After Fresh QNCX Filing

Quince Therapeutics Stock Faces Nasdaq Pressure After Fresh QNCX Filing

18 May 2026
Quince Therapeutics was last quoted at $1.15 before Monday’s Nasdaq open after Nantahala Capital Management disclosed 7.52% beneficial ownership. The company’s latest filing reported no current product candidates and raised substantial doubt about its ability to continue as a going concern. Quince is seeking shareholder approval for another reverse stock split at its June 11 meeting. The company remains out of compliance with Nasdaq’s $50 million market value rule.
Macy’s Gains Pre-Market as Berkshire Buys In — What’s Ahead for Traders

Macy’s Gains Pre-Market as Berkshire Buys In — What’s Ahead for Traders

18 May 2026
Macy’s shares rose in premarket trading after Berkshire Hathaway disclosed a new stake of 3.04 million shares, valued at about $55 million as of March 31. The stock closed Friday at $18.41 and last traded at $18.99 premarket with 128,170 shares exchanged. Macy’s will report first-quarter results on June 3. Tariffs, fuel costs, and weak discretionary spending remain risks for the retailer.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

18 May 2026
ImmunityBio said Monday five U.S. patents protect its Anktiva-plus-BCG bladder cancer treatment through at least 2035, following an exclusive U.S. supply deal with Japan BCG Laboratory. The company plans to seek FDA approval for the Tokyo-172 BCG strain, which is not yet approved in the U.S. ImmunityBio shares last traded at $7.97 before the Nasdaq open.
Why Virax Biolabs Stock Is Jumping Before the Bell Today

Why Virax Biolabs Stock Is Jumping Before the Bell Today

18 May 2026
Virax Biolabs shares jumped in pre-market trading Monday, indicated at $0.3458 after closing Friday at $0.1535. The move followed a sponsored TV segment featuring CEO James Foster and a new SEC filing showing Armistice Capital holds 4.99% of shares. ViraxImmune, the company’s main test, remains in development and is not approved for diagnostic use. No new company press release appeared over the weekend.

Popular

Navitas Semiconductor Stock Is Headed for a Make-or-Break Week After a Wild AI Rally

Navitas Semiconductor Stock Is Headed for a Make-or-Break Week After a Wild AI Rally

17 May 2026
Navitas Semiconductor closed Friday at $21.32, down 4.48% but up 17.14% for the week after raising about $122 million through an at-the-market stock sale. The company sold 6.5 million shares, increasing cash and share count. Investors await Navitas’ May 19 appearance at the J.P. Morgan tech conference. The stock mirrored volatility across the semiconductor sector as the Philadelphia SE Semiconductor Index fell 4% Friday.
Occidental Petroleum stock price whipsaws as oil jumps on Iran conflict; OXY traders eye March 4 deadline
Previous Story

Occidental Petroleum stock price whipsaws as oil jumps on Iran conflict; OXY traders eye March 4 deadline

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 04.03.2026

Go toTop